© Globe Newswire
09.10.2025
KDEV
LISTED
STO
Karolinska Development's portfolio company PharmNovo receives approval to initiate a phase 2a trial of its drug candidate PN6047 in Spain
News Preview
STOCKHOLM, SWEDEN – October 9, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company PharmNovo has received approval from the Spanish regulatory authorities to initiate a phase 2a clinical trial of its drug candidate, PN6047, being developed as a treatment for neuropathic pain. The trial will be conduct...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
SN
LISTED
LSE
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT) code for procedures involving its CARTIHEAL AGILI-C Cartilage Repair Implant, effective January 1, 2027. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
COLO B
LISTED
CPH
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
News Preview
Announcement no. 09/2025Inside information ...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
09.10.2025
TEM
LISTED
NASDAQ
Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, to provide testing and contract research organization (CRO) services in s...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
09.10.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ONT
LISTED
LSE
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
News Preview
Grants Bio-Techne expanded commercial rights to develop a portfolio of genetics products beyond the recently launched AmplideX® Nanopore Carrier Plus Kit
Establishes a framework to define and propose future portfolios
Extends collaboration through 2032, reinforcing Bio-Techne's...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
BAVA
LISTED
CPH
Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
OGI
LISTED
NASDAQ
Organigram Global Launches happly, a New U.S. Hemp-Derived THC Brand Offering Targeted Formulations for Three Mood States; Socialize, Relax, and Sleep
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share, is pleased to announce the launch of happly, its third U.S. hemp-derived delta-9 brand, created specifically for the growing segment of consumers seeking ‘mindful recreation’ with THC products. The launch of happly follow...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
VITR
LISTED
STO
Invitation to Vitrolife Group's presentation of the Q3 2025 interim report
News Preview
GOTHENBURG, Sweden, Oct. 9, 2025 /PRNewswire/ -- Vitrolife AB (publ) will publish its Q3 2025 interim report on Thursday, 23 October 2025 at 08:00 am CEST. A conference call for investors, analysts and financial media will be held at 10:00 am CEST the same day.
The presentation will be held in Eng...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
FAGR
LISTED
EURONEXT
Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 October 2025 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© EQS Newswire
08.10.2025
GXI
LISTED
XETR
Business performance and slower market growth require guidance adjustment
News Preview
Gerresheimer: Business performance and slower market growth require guidance adjustment
Preliminary results for 9M 2025: Revenues +14.6%, Adjusted EBITDA +7.2%
Organic development: Revenues -1.8%, Adjusted EBITDA -7.5%
Subdued demand in the cosmetics and oral liquids segment continues
Separation of Moulded Glass progressing according to plan; ......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.10.2025
GXI
LISTED
XETR
Geschäftsverlauf und schwächeres Marktwachstum erfordern Prognoseanpassung
News Preview
Gerresheimer: Geschäftsverlauf und schwächeres Marktwachstum erfordern Prognoseanpassung
Vorläufige Ergebnisse 9M 2025: Umsatz +14,6 %, Adjusted EBITDA +7,2 %
Organische Entwicklung: Umsatz -1,8 %, Adjusted EBITDA -7,5 %
Weiterhin gedämpfte Marktnachfrage im Bereich Kosmetik und Oral Liquids
Separation Moulded Glass schreitet planmäßig voran; ......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
08.10.2025
GXI
LISTED
XETR
Geschäftsverlauf und schwächeres Marktwachstum erfordern Anpassung der Prognose für 2025
News Preview
Gerresheimer AG: Geschäftsverlauf und schwächeres Marktwachstum erfordern Anpassung der Prognose für 2025
Düsseldorf, 8. Oktober 2025. Die Gerresheimer AG (ISIN: DE000A0LD6E6) passt ihre Prognose für das Geschäftsjahr 2025 an.
Hintergrund ist der schwächere Geschäftsverlauf im dritten Quartal 2025, die weiterhin anhaltende gedämpfte Nachfrage im ......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.10.2025
GXI
LISTED
XETR
Business performance and slower market growth require adjustment of guidance for 2025
News Preview
Gerresheimer AG: Business performance and slower market growth require adjustment of guidance for 2025
Duesseldorf, October 8, 2025. Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer") is adjusting its guidance for the financial year 2025.
This is due to lower business performance in the third quarter of 2025, continued subdued demand in the cos......
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ASND
LISTED
NASDAQ
Ascendis Submits Marketing Authorisation Application to the European Medicines Agency for TransCon® CNP for Treatment of Children with Achondroplasia
News Preview
COPENHAGEN, Denmark, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TransCon CNP (navepegritide) as a treatment for children with achondroplasia, a rare genetic condition that causes skeletal dysplasia and,...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
LIVN
LISTED
NASDAQ
LivaNova to Announce Third-Quarter 2025 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2025 results on Wed., Nov. 5, 2025, at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its third-quarter 2025 results prior to the call.
The audiocast will be accessible at www.livanova.co...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
HLN
LISTED
LSE
Haleon Selects Salesforce Agentforce Life Sciences Cloud for Customer Engagement to Improve Engagement with Pharmacies and Healthcare Professionals with AI
News Preview
Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world’s #1 AI CRM, today announced that Haleon will leverage Salesforce to drive more effective engagement with pharmacies and healthcare professionals worldwide.
This press release features multimedia. View the full rel...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
SOBI
LISTED
STO
Invitation: Sobi's Q3 2025 report
News Preview
STOCKHOLM, Oct. 8, 2025 /PRNewswire/ -- Sobi plans to publish its report for the third quarter of 2025 on 23 October 2025 at 08:00 CEST.
Investors, analysts, and the media are invited to a conference call on the same day at 13:00 CEST, 12:00 BST, and 07:00 EDT. The call will include a presentation...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
POAI
LISTED
NASDAQ
Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy
News Preview
Investment creates the world’s first Strategic Compute Reserve ...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
08.10.2025
CLBX
LISTED
AIMX
Angle PLC Announces Strategy Update
News Preview
Appointment of Executive Chairman, proposed change of name and strategy updateCompany to pursue revised strategy and name change to CelLBxHealth plcDr. Jan Groen, the current Non-Executive Chairman and recognised oncology diagnostic industry veteran, to lead company as Executive ChairmanRevised strategy to sharpen focus on the provision of industry...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on October 1, 2025 to 27 new non-executive employees as equity inducement...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
BAYN
LISTED
XETR
Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest
News Preview
Bayer is proud to announce that Cornfed Farms, a fourth-generation farm operated by the Mohr family, has been designated as the first Bayer ForwardFarm site in the Midwest and the only ForwardFarm in the United States. This recognition places Cornfed Farms as one of 16 farms around the globe, highlighted by Bayer as committed to advancing regenera...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
AFX
LISTED
XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
CELC
LISTED
NASDAQ
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
News Preview
USA News Group
News Commentary
Issued on behalf of GT Biopharma, Inc.
VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
CELC
LISTED
NASDAQ
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
News Preview
USA News Group
News Commentary
Issued on behalf of GT Biopharma, Inc.
VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
AFX
LISTED
XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
CELC
LISTED
NASDAQ
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
News Preview
USA News Group
News Commentary
Issued on behalf of GT Biopharma, Inc.
VANCOUVER, BC, Oct. 7, 2025 /CNW/ -- USA...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
AFX
LISTED
XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
AFX
LISTED
XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
LIVN
LISTED
NASDAQ
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its participation in the International Surgical Sleep Society (ISSS) 2025 Annual Meeting in Indianapolis. The Company will present a five-year analysis of the THN-3 randomized control trial (RCT), which studied the use of its aura6000™ System for the treatmen...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
BAVA
LISTED
CPH
Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population
News Preview
COPENHAGEN, Denmark, October 7, 2025 – Bavarian Nordic A/S (OMX: BAVA) today reported topline results from a clinical study of its MVA-BN® mpox/smallpox vaccine in children 2 to 11 years of age....
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
CYRX
LISTED
NASDAQ
MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars
News Preview
Connected, Intelligent Condition Monitoring Assets that Safeguard Vital Life Science Materials Mark MVE's First Step in its Real-Time Integrated Systems Evolution
NASHVILLE, Tenn., Oct. 7, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX), a global leader in su...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
BAYN
LISTED
XETR
One A Day® Unveils Bold New Brand Identity and Platform: “The ONE for you”
News Preview
One A Day®, the multivitamin and supplement brand by Bayer rooted in 80+ years of nutritional science, today announced a bold new brand identity and positioning designed to better connect with today’s consumers and their evolving health needs. The rebrand, rolling out nationwide this fall, introduces a refreshed visual identity, packaging, and pur...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
BAYN
LISTED
XETR
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
News Preview
Bayer AG and its wholly owned, independently operated subsidiary BlueRock Therapeutics LP, a clinical stage cell therapy company, today announced positive 36-month data from exPDite, a Phase I clinical trial of bemdaneprocel, an investigational cell therapy for the treatment of Parkinson's disease (PD). The data were presented on October 6th at th...
Themefolio
Profiler
Peergroup
© Newsfile
07.10.2025
COPN
LISTED
SIX
Cosmo Pharmaceuticals Announces Regulatory Approval of Winlevi(R) in South Korea
News Preview
Dublin, Ireland--(Newsfile Corp. - October 7, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has approved Winlevi® (clascoterone) cream 1% for the treatment of acne vulgari...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
BIOA B
LISTED
STO
Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
News Preview
STOCKHOLM, Oct. 6, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand name: Leqembi Iqlik) is now available in the U.S. as a maintenance dosing regimen for the treatment of Alzheimer's disease (AD) in patients...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
BIOA B
LISTED
STO
Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
News Preview
STOCKHOLM, Oct. 6, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand name: Leqembi Iqlik) is now available in the U.S. as a maintenance dosing regimen for the treatment of Alzheimer's disease (AD) in patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
DBV
LISTED
EURONEXT
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
News Preview
Châtillon, France, October 6, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
NSIS B
LISTED
CPH
Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters
News Preview
Franklinton, NC, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Novonesis, a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its facilities in Salem, Virginia; West Allis and Madison, Wisconsin; and its North American headquarters in Franklinton, North Carolina, for the national flagship Manufacturing Da...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
AMRX
LISTED
NASDAQ
Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)
News Preview
Kashiv BioSciences, LLC, a fully-integrated biopharmaceutical company, announced that they have submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), and the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA), for ADL-018, a proposed biosimilar to XOLAIR® (omalizumab...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
NUTX
LISTED
NASDAQ
Nutex Health and its Hospitals Earn Record-Breaking 20 Awards and Accolades in Q3
News Preview
HOUSTON, Oct. 6, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physicia...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
TRAW
LISTED
NASDAQ
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
News Preview
NEWTOWN, Pa., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, today announced the appointment of John Leaman, MD, to its board of director...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
FAGR
LISTED
EURONEXT
Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 October 2025 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© ActuNews
03.10.2025
OXUR
LISTED
EURONEXT
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
News Preview
Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1].
Leuven, BELGIUM – 3 October, 2025 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 o...
Themefolio
Profiler
Peergroup
© ActuNews
03.10.2025
OXUR
LISTED
EURONEXT
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
News Preview
Atlas Special Opportunities, LLC heeft 4 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 100.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1.
Leuven, BELGIUM– 3 oktober 2025 – 18u00 CET – Overeenkomstig artikel 15 van de W...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
SN
LISTED
LSE
Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention
News Preview
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound Journal,1 demonstrating the pressure injury prevention mechanism of action of ALLEVYN COMPLETE CARE Foam Dressing and its ability to absorb and dissip...
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
KDEV
LISTED
STO
Karolinska Development’s portfolio company Dilafor receives patent in the US for tafoxiparin in priming of labor
News Preview
STOCKHOLM, SWEDEN – October 3, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has been granted a patent in the US protecting its drug candidate tafoxiparin for its main target indication, priming of labor. The patent will serve as a key asset as Dilafor advances into phase 3 clinical deve...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
OSE
LISTED
EURONEXT
Appointment of Marc Le Bozec as Interim CEO
News Preview
Appointment of Marc Le Bozec as Interim CEO...
Themefolio
Profiler
Peergroup
© ActuNews
02.10.2025
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – October 2, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notification as follows:
Oxurion received a transparency notification on October 2, 2025, from Atlas Special Opportun...
Themefolio
Profiler
Peergroup
© ActuNews
02.10.2025
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 2 oktober 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen:
Oxurion ontving een transparantiekennisgeving o...
Themefolio
Profiler
Peergroup
© EQS Newswire
02.10.2025
FYB
LISTED
XETR
Formycon sichert US-Vermarktungsstart für Aflibercept-Biosimilar FYB203 durch Settlement-Vereinbarung mit Regeneron
News Preview
Pressemitteilung // 2. Oktober 2025
Formycon sichert US-Vermarktungsstart für Aflibercept-Biosimilar FYB203 durch Settlement-Vereinbarung mit Regeneron
Formycon und seine Partner haben mit Regeneron eine Vergleichs- und Lizenzvereinbarung für FYB203/AHZANTIVE®1 (Aflibercept-mrbb) abgeschlossen
Die anhängigen Verfahren vor dem US-Bezirksgericht ......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.10.2025
FYB
LISTED
XETR
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
News Preview
Press Release // October 2, 2025
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
Formycon and its partners entered into a settlement and license agreement with Regeneron for FYB203/AHZANTIVE® (Aflibercept-mrbb)
Pending litigation at the U.S. District Court fo......
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
KPTI
LISTED
NASDAQ
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NEWTON, Mass., Oct. 1, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 333 restricted stock units (RSUs) to one newly-hired employee. This RSU award was granted as of September 30, 2025 (the "Gran...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
GLPG
LISTED
EURONEXT
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business
News Preview
Mechelen, Belgium; October 1, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and its Board of Directors today issued the following statement:...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
TEM
LISTED
NASDAQ
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
News Preview
Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM) and a pioneer in clinical genomic testing, today announced an enhancement to the Ambry CARE Program® (CARE), Ambry’s digital platform that streamlines cancer risk assessment and genetic testing workflows. The update integrates breast density into the Tyrer-Cuzick (TC) b...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
SN
LISTED
LSE
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty
News Preview
Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
CYRX
LISTED
NASDAQ
Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France
News Preview
The 55,000-Square-Foot Facility is the Latest Addition to Cryoport Systems' Global Supply Chain Center Network
Designed to Support Complex Life Sciences Supply Chain Needs, Including Biologistics, BioServices and Future Cryopreservation Services Worldwide...
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2025
GXI
LISTED
XETR
Gerresheimer Expands Wertheim Site with new Production Facility for Ready-to-fill Vials
News Preview
Gerresheimer Expands Wertheim Site with new Production Facility for Ready-to-fill Vials
New production hall for RTF vials and innovative EZ-fill Smart packaging platform
Best possible protection for sensitive biologics
Total investment volume of around EUR 30 million
Around 50 new jobs for skilled workers from the region
Düsseldorf/Wertheim, Ge......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
